1. Home
2. Celgene Corp /de/

Insider Trading History of Celgene Corp /de/

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Celgene Corp /de/ since 2013. The trader's CIK number is 816284. At the time of the last reporting, Celgene Corp /de/ was the 10% Owner of Acceleron Pharma Inc. (stock ticker symbol XLRN). Also see all insider trading activities at Acceleron Pharma Inc.

Note that in the past CELGENE CORP /DE/ also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Celgene Corp /de/

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	AGIO	1,873,725	$92,749,386	0	$0	0	$0

Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Celgene Corp /de/

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2014	EPZM	340,000	$9,945,000	0	$0	0	$0
2013	EPZM	66,666	$999,990	0	$0	0	$0

Yearly summary of insider trading at Globeimmune Inc (GBIM) by Celgene Corp /de/

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2014	GBIM	200,000	$2,000,000	0	$0	0	$0

Yearly summary of insider trading at Acceleron Pharma Inc (XLRN) by Celgene Corp /de/

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	XLRN	706,206	$30,366,858	0	$0	0	$0
2017	XLRN	745,592	$27,586,904	0	$0	0	$0
2016	XLRN	800,000	$32,000,000	0	$0	0	$0
2014	XLRN	1,400,000	$62,146,000	0	$0	0	$0
2013	XLRN	666,667	$10,000,005	0	$0	0	$0

Yearly summary of insider trading at Alliqua, Inc. (ALQA) by Celgene Corp /de/

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	ALQA	4,000,000	$2,000,000	0	$0	0	$0
2015	ALQA	659,340	$2,999,997	0	$0	0	$0
2014	ALQA	714,286	$5,000,002	0	$0	0	$0

Yearly summary of insider trading at Jounce Therapeutics, Inc. (JNCE) by Celgene Corp /de/

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	JNCE	625,000	$10,000,000	0	$0	0	$0

Yearly summary of insider trading at Crispr Therapeutics Ag (CRSP) by Celgene Corp /de/

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	CRSP	0	$0	1,112,446	$21,118,113	0	$0
2016	CRSP	800,150	$11,202,100	0	$0	0	$0

Insider trading activities at 7 companies by Celgene Corp /de/:

1. Agios Pharmaceuticals, Inc. (AGIO)

2. Epizyme, Inc. (EPZM)

3. Globeimmune Inc (GBIM)

4. Acceleron Pharma Inc (XLRN)

5. Alliqua, Inc. (ALQA)

6. Jounce Therapeutics, Inc. (JNCE)

7. Crispr Therapeutics Ag (CRSP)

Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Celgene Corp /de/

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-04-24	AGIO	Buy	624,575	49.50	30,916,462
2017-04-24	AGIO	Buy	624,575	49.50	30,916,462
2017-04-24	AGIO	Buy	624,575	49.50	30,916,462

Table 2. Insider trading of Epizyme, Inc. (EPZM) by Celgene Corp /de/

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2014-02-10	EPZM	Buy	340,000	29.25	9,945,000
2013-06-05	EPZM	Buy	66,666	15.00	999,990

Table 3. Insider trading of Globeimmune Inc (GBIM) by Celgene Corp /de/

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2014-07-08	GBIM	Buy	200,000	10.00	2,000,000

Table 4. Insider trading of Acceleron Pharma Inc (XLRN) by Celgene Corp /de/

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-01-18	XLRN	Buy	706,206	43.00	30,366,858
2017-09-25	XLRN	Buy	745,592	37.00	27,586,904
2016-01-11	XLRN	Buy	800,000	40.00	32,000,000
2014-05-05	XLRN	Buy	1,100,000	42.86	47,146,000
2014-01-28	XLRN	Buy	300,000	50.00	15,000,000
2013-09-24	XLRN	Buy	666,667	15.00	10,000,005

Table 5. Insider trading of Alliqua, Inc. (ALQA) by Celgene Corp /de/

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-02-27	ALQA	Buy	4,000,000	.50	2,000,000
2015-05-04	ALQA	Buy	659,340	4.55	2,999,997
2014-04-14	ALQA	Buy	714,286	7.00	5,000,002

Table 6. Insider trading of Jounce Therapeutics, Inc. (JNCE) by Celgene Corp /de/

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-02-01	JNCE	Buy	625,000	16.00	10,000,000

Table 7. Insider trading of Crispr Therapeutics Ag (CRSP) by Celgene Corp /de/

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-12-01	CRSP	Sale	87,991	19.10	1,680,628
2017-11-17	CRSP	Sale	51,282	18.44	945,640
2017-11-16	CRSP	Sale	105,000	18.39	1,930,950
2017-11-15	CRSP	Sale	15,000	17.67	265,050
2017-11-14	CRSP	Sale	14,907	17.19	256,251
2017-11-13	CRSP	Sale	65,093	17.76	1,156,051
2017-11-10	CRSP	Sale	10,000	17.28	172,800
2017-11-29	CRSP	Sale	4,263	19.25	82,062
2017-11-28	CRSP	Sale	5,080	19.22	97,637
2017-11-27	CRSP	Sale	27,990	19.75	552,802
2017-11-24	CRSP	Sale	26,010	20.00	520,200
2017-11-22	CRSP	Sale	256,000	19.76	5,058,560
2017-11-20	CRSP	Sale	158,718	19.02	3,018,816
2017-11-09	CRSP	Sale	20,000	17.08	341,599
2017-11-08	CRSP	Sale	16,875	18.06	304,762
2017-11-07	CRSP	Sale	23,000	18.54	426,420
2017-11-06	CRSP	Sale	79,327	18.89	1,498,487
2018-11-21	CRSP	Sale	80,000	19.25	1,540,000
2017-12-04	CRSP	Sale	30,485	19.47	593,542
2017-11-30	CRSP	Sale	12,666	19.04	241,160
2017-11-03	CRSP	Sale	22,759	19.10	434,696
2016-10-24	CRSP	Buy	800,150	14.00	11,202,100

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Celgene Corp /de/ (10% Owner of Acceleron Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month